3D Printing for Healthcare Applications

3D Printing for Healthcare Applications

Technology that could revolutionize pharmaceutical and biotechnology manufacturing

RELEASE DATE
30-Dec-2016
REGION
Global
Research Code: D75D-01-00-00-00
SKU: HC02700-GL-TR_19246
$4,950.00
In stock
SKU
HC02700-GL-TR_19246
$4,950.00
DownloadLink

Pay by invoice

ENQUIRE NOW

Description

3D printing (3DP) will have a strong commercial impact across major consumer segments of the global healthcare sectors, an industry that necessitates efficient production of primarily complex or personalized products. The opportunity to customize drugs, active pharmaceutical ingredients (APIs) and medical devices drives an era of personalized medicine. 3D printing has garnered a place on the finisher’s podium as one of the highly investigated technologies for potential adoption by a plethora of key participants in the healthcare industry.

Table of Contents

1.1 Research Methodology

1.2 Key Findings

2.1 Aspects of 3D Printing versus Traditional Manufacturing

2.2 Crowdsourcing and 3D Printing

2.3 Crowdsourcers Leading the Change

2.4 Mass Customization and 3D Printing

3.1 Major 3D Printing Technologies

3.2 Comparative Analysis of 3D Printing Technologies

4.1 3D Printing has a Dynamic Impact across Multiple Verticals, which Largely Include the Healthcare and Industrial Sectors

4.2 3D Printing Is a Platform for Innovation across Healthcare

4.3 Recent Events across the Healthcare Industry Due to 3D Printing

4.4 Prosthetics, Bone Grafts, and Dental Prosthetics have the Highest Innovation and Adoption rates for 3D Printing Applications

4.5 Prosthetics, Bone Grafts, and Dental Prosthetics with the Highest Innovation and Adoption Rates for 3D Printing Applications

4.6 Prosthetics, Bone Grafts, Ears and Vascular Tissues and Dental Prosthetics with the Highest Innovation and Adoption Rates for 3D Printing Applications

4.7 Prosthetics, Bone Grafts, Ears and Vascular Tissues and Dental Prosthetics with the Highest Innovation and Adoption Rates for 3D Printing Applications

5.1 Business Model of Additive Manufacturing 3D Printer Manufacturers

5.2 Business Model of Additive Manufacturing Material Providers

5.3 Business Model of Additive Manufacturing Service Providers

5.4 Comparative Assessment of 3D Printing Technologies

5.4 Comparative Assessment of 3D Printing Technologies (continued)

5.5 Company Profile – Stratasys

5.6 Stratasys Activities in the Dental Industry – These dental 3D Printers are having a Huge Impact on the Dental Industry

5.7 The Use of Stratasys Printers in the Dental Industry – Case Studies Being used for Various Application in the Dental Industry

5.8 Stratasys Activities in the Healthcare Industry

5.9 The Use of Stratasys Printers in the Healthcare Industry

5.10 Company Profile – 3D Systems

5.11 3D Systems’ Activities in the Healthcare Industry

5.12 3D Systems’ Printers Used in the Healthcare Industry

6.1 3D Printing – Key Areas of Impact across the Pharmaceutical Sector

6.2.1 Disease Treatment and Drug Discovery Process: Pharmaceutical Requirement from 3DP

6.2.2 Disease Treatment and Drug Discovery Process: 3DP Impact on Drug Discovery Value Chain

6.2.3 Disease Treatment and Drug Discovery Process: Innovations across Manufacturing Techniques

6.2.4 Disease Treatment and Drug Discovery Process: Impact of Printers across Pharma Innovations

6.2.5 Disease Treatment and Drug Discovery Process: 3D Printing Impact across Pharma Innovations

6.2.6 Disease Treatment and Drug Discovery Process: Tablet Formulation Types and Requirements

6.2.7 Disease Treatment and Drug Discovery Process: Case study – Aprecia Pharmaceuticals

6.3 Company Profile: Aprecia Pharmaceutical

6.3.1 Company Profile: Aprecia Pharmaceutical – Technology/Product

6.4.1 Disease Treatment & Drug Discovery Process – Impact on Drug Screening and Toxicity Testing

6.4.2 Disease Treatment & Drug Discovery Process – Innovation Landscape

6.4.2 Disease Treatment & Drug Discovery Process – Innovation Landscape (continued)

6.4.2 Disease Treatment & Drug Discovery Process – Innovation Landscape (continued)

6.4.3 Disease Treatment & Drug Discovery Process – Case study : Organovo

6.4.4 Disease Treatment & Drug Discovery Process – Innovations in Emerging Markets – India & China

6.5.1 Operational Models of Pharma Business – 3DP a Major Point of Interest for Contract Manufacturers with Pharma Clients

6.5.2 Operational Models of Pharma Business – Impact across Pharmaceutical R&D

6.5.3 Operational Models of Pharma Business – Benefits of 3D Printing Across Pharma Applications

6.5.4 Operational Models of Pharma Business – Current 3DP Implementation Strategies

6.5.5 Operational Models of Pharma Business – Current 3DP Implementation Strategies by Big Pharma

6.6 Drug Supply Chain: How is 3D Printing Interrupting the Drug Supply Chain?

6.7 Impact across Emerging Markets

6.8 Regulatory Landscape

6.9 Drivers and Restraints – Factors Aiding/Hindering Adoption of 3D Printing in the Pharma Industry

6.10 Drivers Explained

6.11 Restraints Explained

6.12 Digital Fabrication’s Potential Impact on Drug Accessibility in Emerging Countries

6.13 Strategic Recommendations on Steps Forward

7.1 Growth Opportunity: 3D Printing for Healthcare

7.2 Major Growth Opportunities for 3DP in Healthcare

7.3 Strategic Imperatives for 3DP Technology Stakeholders

7.4 Epileptic Solutions Using 3D Printed Drugs – Aprecia Pharmaceutical, US

8.1 Patent Search Scope

8.2 Patent Publishing Trends, Global, 2011–2015

8.3 Top 20 Patent holders, Global, 2010–2015

8.4 Patents per Source Jurisdiction (Top 10 Patent offices), Global, 2010–2015

8.5 Key Company Contacts

Legal Disclaimer

9.1 The Frost & Sullivan Story

9.2 Value Proposition: Future of Your Company & Career

9.3 Global Perspective

9.4 Industry Convergence

9.5 360º Research Perspective

9.6 Implementation Excellence

9.7 Our Blue Ocean Strategy

Related Research
3D printing (3DP) will have a strong commercial impact across major consumer segments of the global healthcare sectors, an industry that necessitates efficient production of primarily complex or personalized products. The opportunity to customize drugs, active pharmaceutical ingredients (APIs) and medical devices drives an era of personalized medicine. 3D printing has garnered a place on the finisher’s podium as one of the highly investigated technologies for potential adoption by a plethora of key participants in the healthcare industry.
More Information
No Index No
Podcast No
Author Madhumitha Rangesa
Industries Healthcare
WIP Number D75D-01-00-00-00
Is Prebook No